120 related articles for article (PubMed ID: 22876660)
1. [The current clinical status of kidney cancers in patients with the VHL disease in Japan: a nationwide epidemiological survey].
Shuin T; Shinohara N; Yao M; Yamasaki I; Tamura K; Kamada M
Nihon Hinyokika Gakkai Zasshi; 2012 May; 103(3):552-6. PubMed ID: 22876660
[TBL] [Abstract][Full Text] [Related]
2. [Clinical status of Von Hippel-Lindau disease associated pheochromocytoma in Japan: a national epidemiologic survey].
Shuin T; Yao M; Shinohara N; Yamasaki I; Tamura K
Nihon Hinyokika Gakkai Zasshi; 2012 May; 103(3):557-61. PubMed ID: 22876661
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey.
Igarashi H; Ito T; Nishimori I; Tamura K; Yamasaki I; Tanaka M; Shuin T
J Gastroenterol; 2014 Mar; 49(3):511-6. PubMed ID: 23543325
[TBL] [Abstract][Full Text] [Related]
4. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
[TBL] [Abstract][Full Text] [Related]
5. Development of Database and Genomic Medicine for von Hippel-Lindau Disease in Japan.
Takayanagi S; Mukasa A; Nakatomi H; Kanno H; Kuratsu JI; Nishikawa R; Mishima K; Natsume A; Wakabayashi T; Houkin K; Terasaka S; Yao M; Shinohara N; Shuin T; Saito N
Neurol Med Chir (Tokyo); 2017 Feb; 57(2):59-65. PubMed ID: 28070114
[TBL] [Abstract][Full Text] [Related]
6. A genetic register for von Hippel-Lindau disease.
Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
[TBL] [Abstract][Full Text] [Related]
8. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
9. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
10. Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease.
Singh AD; Nouri M; Shields CL; Shields JA; Smith AF
Ophthalmology; 2001 Oct; 108(10):1907-11. PubMed ID: 11581072
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for survival in patients with von Hippel-Lindau disease.
Wang JY; Peng SH; Li T; Ning XH; Liu SJ; Hong BA; Liu JY; Wu PJ; Zhou BW; Zhou JC; Qi NN; Peng X; Zhang JF; Ma KF; Cai L; Gong K
J Med Genet; 2018 May; 55(5):322-328. PubMed ID: 29330336
[TBL] [Abstract][Full Text] [Related]
13. Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.
Jilg CA; Neumann HP; Gläsker S; Schäfer O; Leiber C; Ardelt PU; Schwardt M; Schultze-Seemann W
Fam Cancer; 2012 Sep; 11(3):387-94. PubMed ID: 22426863
[TBL] [Abstract][Full Text] [Related]
14. von Hippel-Lindau disease with bilateral multiple renal cell carcinoma managed by right radical nephrectomy and left repeat partial nephrectomy.
Ansari MS; Gupta NP; Kumar P
Int Urol Nephrol; 2003; 35(4):471-3. PubMed ID: 15198146
[TBL] [Abstract][Full Text] [Related]
15. The incidence of consecutive manifestations in Von Hippel-Lindau disease.
van der Horst-Schrivers ANA; Sluiter WJ; Kruizinga RC; van Leeuwaarde RS; Giles R; Olderode-Berends MJW; Links TP
Fam Cancer; 2019 Jul; 18(3):369-376. PubMed ID: 31087189
[TBL] [Abstract][Full Text] [Related]
16. Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group.
Oudard S; Elaidi R; Brizard M; Le Rest C; Caillet V; Deveaux S; Benoit G; Corréas JM; Benoudiba F; David P; Gaudric A; Hammel P; Joly D; Timsit MO; Méjean A; Richard S
Oncotarget; 2016 Dec; 7(51):85306-85317. PubMed ID: 27852035
[TBL] [Abstract][Full Text] [Related]
17. VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma.
Yao M; Yoshida M; Kishida T; Nakaigawa N; Baba M; Kobayashi K; Miura T; Moriyama M; Nagashima Y; Nakatani Y; Kubota Y; Kondo K
J Natl Cancer Inst; 2002 Oct; 94(20):1569-75. PubMed ID: 12381710
[TBL] [Abstract][Full Text] [Related]
18. [Renal cell carcinoma in von Hippel-Lindau disease. Nephron sparing surgery.].
Urbieta Anza A; Llarena Ibarguren R; Tomás Zabala Egurrola JA; Gutierrez Zurimendi G; Iturregui Del Pozo AM; Arruza Echevarria A
Arch Esp Urol; 2018 Nov; 71(9):757-764. PubMed ID: 30403378
[TBL] [Abstract][Full Text] [Related]
19. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
[TBL] [Abstract][Full Text] [Related]
20. First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
Roma A; Maruzzo M; Basso U; Brunello A; Zamarchi R; Bezzon E; Pomerri F; Zovato S; Opocher G; Zagonel V
Fam Cancer; 2015 Jun; 14(2):309-16. PubMed ID: 25391617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
